Author

D. Arambilet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Bigas· 1 shared C. Gekas· 1 shared H. Heyn· 1 shared I. Marquez-Lopez· 1 shared I. Sentis· 1 shared J. L. Trincado· 1 shared L. Espinosa· 1 shared M. Camos· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bigas

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

β-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia

V. Garcia-Hernandez, D. Arambilet, Y. Guillen, T. Lobo, C. Gekas, N. Vega-Garcia, I. Sentis, J. L. Trincado, I. Marquez-Lopez, H. Heyn, M. Camos, L. Espinosa, A. Bigas

The paper identifies a β-catenin-regulated RNA biosynthesis program linked to therapy resistance in T-ALL and suggests combining chemotherapy with β-catenin inhibitors to improve treatment outcomes.

bioRxiv · Jul 7, 2022Cancer Biology